Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001628280-16-018870
Filing Date
2016-08-11
Accepted
2016-08-10 20:11:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B4 imuc_s1.htm 424B4 529508
2 capture.jpg GRAPHIC 14802
  Complete submission text file 0001628280-16-018870.txt   545902
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-211763 | Film No.: 161822717
SIC: 2834 Pharmaceutical Preparations